Novartis Hematology is the place where you can bring your purpose to life through the work that you do to create a better life for patients with hematologic diseases and for their families. You will work with people who are passionate, smart and who will support you to be extraordinary.
The World Wide Disease Lead (Benign Hem) is the ultimate leader of the brand strategy for all products and indications within a disease area (including companion diagnostics) and ensures that we leverage the full ground-breaking potential of our brands. It co-leads the disease area strategy and ensures that we maximize the value of our portfolio.
Key responsibilities * Leads the co-creation of the brand strategy (IDAPS), including financial forecasts and budgets and cross-indication planning, and the co-creation and implementation of global IDAPS tactical plan via the Worldwide X-functional Team and the Worldwide Brand Team. Own the present and future brand performance of the disease area by providing guidance on forecast assumptions and works hand-in hand with the regions on budget and long-term forecast in key countries. * Leads global launch preparation by ensuring proper resourcing and the delivery of key commercial activities in line with iLEX2.0 to maximize success on 4 core markets (US, Germany, China and Japan). Coordinates with global medical affairs, global market access and GDD and regularly reports launch progress at launch SteerCos. * Leads and coordinates the insights generation and provides competitive intelligence, in order to identify trends, opportunities and threats (worldwide and in key local markets) and propose corresponding measures. * Core member of the GPT. Leads the commercial sub-team and works hand-in hand with Worldwide X-functional Team to provide consolidated commercial input into key GPT decisions. Drives life-cycle management in order to maximize the potential of the brand. * Shapes portfolio strategy by co-leading the disease area strategy (DAS) with GDD and NIBR with input from other OBU functions (BD&L, GMA and GVA) and ensures the quarterly monitoring/reporting of the implementation. Monitors external opportunities which are in line with the disease area strategy and support BD&L in deal assessment. * Lead the Global Disease Team, including Global Brand Leads (GBLs), Global Indication Leads (GIL) and Global Disease Strategy Leads (GDSL) as direct reports, and provides coaching and development, in order to maximize their potential. * Fosters an externally focused culture by frequently consulting with key external experts on market trends, new transformational technologies and with patient organizations on patient solutions and creates a culture of innovations by ensure digital upskilling of the global and country marketing teams and experimenting and implementing new marketing technologies. * Ensures full compliance to P3 principles across disease area including regular updates and training of the team.